Anzeige
Mehr »
Login
Dienstag, 01.04.2025 Börsentäglich über 12.000 News von 695 internationalen Medien
Kurs-Explosion voraus?: Diese kaum bekannte Aktie bohrt jetzt im Hotspot - und du erfährst es als Erster!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A40P4H | ISIN: SE0023261292 | Ticker-Symbol: 5JD0
Frankfurt
01.04.25
09:17 Uhr
1,910 Euro
-0,050
-2,55 %
Branche
Biotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
EXPRES2ION BIOTECH HOLDING AB Chart 1 Jahr
5-Tage-Chart
EXPRES2ION BIOTECH HOLDING AB 5-Tage-Chart

Aktuelle News zur EXPRES2ION BIOTECH Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
13:39EXPRES2ION BIOTECH HOLDING AB: ExpreS2ion Provides Pipeline Update2
MoEXPRES2ION BIOTECH HOLDING AB: ExpreS2ion Announces Leadership Transition in R&D2
09.02.ExpreS2ion Biotech: Herausforderungen und Chancen im Biotech-Sektor2
EXPRES2ION BIOTECH Aktie jetzt für 0€ handeln
06.02.ExpreS2ion Biotech Holding AB: ExpreS2ion announces financial results for the fourth quarter of 2024133Hørsholm, Denmark, 6 February 2025 - ExpreS2ion Biotech Holding AB ("ExpreS2ion") today announces its fourth quarter and full-year financial results for 2024. The report is available as an attachment...
► Artikel lesen
09.01.EXPRES2ION BIOTECH HOLDING AB: ExpreS2ion to Present in Upcoming Investor and Scientific Events1
11.12.24EXPRES2ION BIOTECH HOLDING AB: Publication of clinical Phase IIb trial data for the adjuvanted RH5.1 blood-stage malaria vaccine4
11.12.24EXPRES2ION BIOTECH HOLDING AB: Analysguiden Publishes Research Report on ExpreS2ion Biotech with Price Target of SEK 916
06.12.24EXPRES2ION BIOTECH HOLDING AB: Warrants of series TO 10 were exercised to approximately 69 percent and ExpreS2ion receives approximately SEK 10 million3
02.12.24EXPRES2ION BIOTECH HOLDING AB: ExpreS2ion announces approval to initiate a Phase I clinical trial of ES2B-C001, its novel therapeutic vaccine, being developed for HER2-expressing breast cancer2
02.12.24EXPRES2ION BIOTECH HOLDING AB: ExpreS2ion publishes video presentations from Biostock Life Science Summit and Analysguiden Stora Aktiedagarna2
02.12.24EXPRES2ION BIOTECH HOLDING AB: Last day of trading in warrants of series TO 10 in Expres2ion Biotech Holding AB is today, 2 December 20243
21.11.24EXPRES2ION BIOTECH HOLDING AB: Full commitments from members of ExpreS2ion's Board and Management holding warrants of series TO 102
20.11.24EXPRES2ION BIOTECH HOLDING AB: ExpreS2ion announces the start of the exercise period for warrants of series TO 104
18.11.24EXPRES2ION BIOTECH HOLDING AB: ExpreS2ion to present in upcoming investor and scientific events1
14.11.24EXPRES2ION BIOTECH HOLDING AB: ExpreS2ion announces TO 10 warrant exercise price and start of exercise period6
14.11.24ExpreS2ion Biotech Holding AB: ExpreS2ion announces financial results for the third quarter of 2024141Hørsholm, Denmark, 14 November 2024 - ExpreS2ion Biotech Holding AB ("ExpreS2ion") today announces its third quarter and year-to-date financial results for 2024. The report is available as an attachment...
► Artikel lesen
12.11.24EXPRES2ION BIOTECH HOLDING AB: ExpreS2ion and Evaxion announce positive preclinical data for cytomegalovirus (CMV) vaccine program ES2B-I0022
05.11.24EXPRES2ION BIOTECH HOLDING AB: ExpreS2ion CEO talking to BioStock about partnering efforts at BIO-Europe3
04.11.24EXPRES2ION BIOTECH HOLDING AB: ExpreS2ion Biotech will present at the BioStock Life Science Summit, November 213
31.10.24EXPRES2ION BIOTECH HOLDING AB: ExpreS2ion to present in upcoming investor and scientific events2
Seite:  Weiter >>
33 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1